Viewing Study NCT03673384



Ignite Creation Date: 2024-05-06 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 12:54 PM
Study NCT ID: NCT03673384
Status: COMPLETED
Last Update Posted: 2018-09-17
First Post: 2018-08-16

Brief Title: Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation
Sponsor: Nanhua University
Organization: Nanhua University

Study Overview

Official Title: Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation
Status: COMPLETED
Status Verified Date: 2018-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Allergic rhinitis is one of the chronic illnesses At present the major treatments for allergic rhinitis are avoiding allergens medical treatment and surgery However inadequate effects and possible side effects of these treatments are still problems to these patients Therefore to find an effective non-medical and non-surgical treatment will be of great help in treating patients with allergic rhinitis

Infrared-C far-infrared ray irradiation is able to promote normal operation of autonomic nervous system to improve blood circulation and thereby assumed to relieve discomfort symptoms of patients with vascular specific or non-specific allergic rhinitis Consequently infrared-C ray irradiation is expected to be effective for the treatment of allergic rhinitis

The investigators aimed to probe the adjunct effects of infrared-C ray irradiation in terms of infrared-C hot compress in improving allergy symptoms like sneezing rhinorrhea nasal obstruction nose and conjunctiva itching during a medical treatment for patients with allergic rhinitis Moreover the impact of infrared-C irradiation on health and life quality enhancement will also be studied
Detailed Description: This is a quasi-experimental design The study subjects are recruited from patients visited to a Ear-Nose-Throat Out Patient Department in a regional teaching hospital in south Taiwan The sampling method is purposive sampling The inclusion criteria are adults between 20 and 50 year-old with a definite clinical diagnosis of allergic rhinitis Subjects were randomly divided into experimental and control groups Thirty persons in the experimental group received both medical and infrared-C ray irradiation by hot compress as intervention On the other hand twenty persons in the control group took only medical treatment Patients in experimental group received anti-histamine steroid nasal spray and infrared-C ray irradiation for 40 minutes each time and more than three times per week The regions for hot compress included head neck and shoulder back and lower back which covered many acupuncture points frequently used by traditional Chinese medicine for the treatment of allergic rhinitis including point Dazhui GV14 Dingchuan EX-B1 Dazhu BL11 Fengmen BL12 Feishu BL13 Pishu BL20 and Shenshu BL23 In addition patients also received infrared-C hot compress over face eyes and nose during acute stage of allergic rhinitis The investigators used a questionnaire as a pre-test to collect basic information of the subjects and Taiwans Sino-Nasal Outcome Test-20 SNOT-20 nose and sinusitis evaluation form as pre-middle and post-test to evaluate the effect of the interventions World Health Organization Quality of Life Instruments WHOQOL-BREF and Taiwans concise edition of WHOQOL II questionnaire were also used as basic data collection tools for allergic rhinitis Furthermore blood tests for patients serum Immunoglobulin E IgE and eosinophil cationic protein levels were determined before and after experiment Pre-test for the experimental and control group was carried out before the intervention the first post-test was performed 4 weeks later and the second post-test was carried out 12 weeks later Data was analyzed by SPSS 220 software

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None